Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: A Saudi national diabetes registry-based study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Al Rubeaan, Khalid ^a   Youssef, Amira M ^b   Subhani, Shazia N ^c   Ahmad, Najlaa A ^b   Al Sharqawi, Ahmad H ^b   Al Mutlaq, Hind M ^d   David, Satish K ^b   AlNaqeb, Dhekra ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE REGISTRY; END STAGE RENAL DISEASE; EPIDEMIC; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERLIPIDEMIA; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SAUDI ARABIA; SCREENING TEST; SEX DIFFERENCE; SMOKING; AGED; ALBUMINURIA; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EPIDEMIOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; REGISTER; RISK; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; REGISTRIES; RISK FACTORS; SAUDI ARABIA; SEX FACTORS;

EID: 84896746030     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088956     Document Type: Article

References (31)

1. Carstensen B, Kristensen JK, Ottosen P, BorchJohnsen K, Steering Group of the National Diabetes Register (2008) The Danish National Diabetes Register: Trends In Incidence, Prevalence And Mortality. Diabetologia 51(12): 2187-96.
2. Ford DJ, Fogarty DG, Steenkamp R, Tomson CRV, Ben-Shlomo Y, et al. (2010) Chapter 13: The UK Renal Registry Advanced CKD Study: frequency of incorrect reporting of date of start of RRT. Nephron Clinical Practice 115(1): c271-c78.
3. Patient Registries (2010) In: Gliklich RE, Dreyer NA, (eds) Registries for Evaluating Patient Outcomes: A User's Guide, 2nd edition. Agency for Healthcare Research and Quality (US) http://www.ncbi.nlm.nih.gov/books/NBK49448/ .
4. th ed. http://www.idf.org/diabetesatlas/5e/middle-east-and-north-africa.
5. AlNozha MM, AlMaatouq MA, AlMazrou YY, AlHarthi SS, Arafah MR, et al.(2004) Diabetes mellitus In Saudi Arabia. Saudi Med J 25(11): 1603-10. (Pubitemid 39646631)
6. Shen FC, Chen CY, Su SC, Liu RT (2009) The Prevalence And Risk Factors Of Diabetic Nephropathy In Taiwanese Type 2 Diabetes - A Hospital Based Study. ActaNephrologica 23: 2.
7. Magee GM, Hunter SJ, Cardwell CR, Savage G, Kee F, et al. (2010) Identifying additional patients with diabetic nephropathy using the UK primary care initiative. Diabet Med 27(12): 1372-8. doi:10.1111/j.1464 5491.2010.03105.x.
8. Ngarmukos C, Bunnag P, Kosachunhanun N, Krittiyawong S, Leelawatana R, et al. (2006) Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy. J Med Assoc Thai 89 (1): S37-42. (Pubitemid 44903898)
9. Alwakeel JS, Sulimani R, AlAsaad H, AlHarbi A, Tarif N, et al. (2008) Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia. Ann Saudi Med 28(4): 260-6.
10. Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, et al. (2007) Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults With Type 1 Diabetes. Diabetes Care 30(10): 2523-8.
11. Alwakeel JS, Isnani AC, Alsuwaida A, AlHarbi A, Shaikh SA, et al. (2011) Factors affecting the progression of diabetic nephropathy and its complications: A single-center experience in Saudi Arabia. Ann Saudi Med 31(3): 236-242.
12. Mohan V, Meera R, Premalatha G, R Deepa, P Miranda, et al. (2000) Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India. Postgrad Med J 67: 569-573.
13. Klein R, Klein BE, Moss SE. (1993) Prevalence of microalbuminuria in olderonset diabetes Diabetes Care 16: 1325-1330.
14. Unnikrishnan R, Rema M, Pradeepa R, Deepa M, Shanthirani CS, et al.(2007) Prevalence And Risk Factors Of Diabetic Nephropathy In An Urban South Indian Population. Diabetes Care 30: 8.
15. Alzaid AA, Sobki S, De Silva V (1994) Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study. Diabetes Res Clin Pract 26(2): 115-20.
16. Gall MA, Hougaard P, BorchJohnsen K, Parving HH (1997). Risk factors for development of incipient and overt diabetic nephropathy in patients with noninsulin dependent diabetes mellitus: prospective, observational study. BMJ 314(7083): 783-8. (Pubitemid 27117048)
17. Ravid M, Brosh D, RavidSafran D, Levy Z, Rachmani R (1997) Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998; 158(9): 998-1004. (Pubitemid 28213577)
18. Maric C, Sullivan S (2008) Estrogens and the Diabetic Kidney. Gend Med 5 Suppl A: S103-13. doi:10.1016/j.genm.2008.03.010.
19. Yang CW, Park KT, Kim YS, Kim YL, Lee YS (2011) Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study). Nephrol Dial Transplant 26: 3249-3255.
20. AlNozha MM, AlMazrou Y, AlMaatouq M, Arafah MR, Khalil MZ, et al. (2005) Obesity in Saudi Arabia. Saudi Med J 26 (5): 824-829. (Pubitemid 40903350)
21. Viswanathan V, Tilak P, Kumpatla S (2012) Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study. Indian J Med Res 136: 46-53.
22. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International 63: 225-232. doi:10.1046/j.1523-1755.2003.00712.x. (Pubitemid 35463925)
23. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, et al. (2006) Risk Factors for Renal Dysfunction in Type 2 Diabetes U.K. Prospective Diabetes Study 74. Diabetes 55: 6 1832-1839.
24. Keane WF, Brenner BM, Zeeuw D, Grunfeld JP, McGill J, et al. (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study. Kidney International 63: 1499-1507. (Pubitemid 36350016)
25. Mehler PS, Jeffers BW, Biggerstaff SL, Schrier RW (1998) Smoking as a Risk Factor for Nephropathy in Non-Insulin-Dependent Diabetics. J Gen Intern Med 13: 842-845. (Pubitemid 29009297)
26. Jarallah JS, AlRubeaan KA, AlNuaim AR, AlRuhaily AA, Kalantan KA (1999) Prevalence and determinants of smoking in three regions of Saudi Arabia. Tobacco Control; 8: 53-56.
27. Gross JL, Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, et al. (2005) Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care 28: 176-188.
28. Fioretto P, Bruseghin M, Berto I, Gallina P, Manzato E, et al. (2006) Renal protection in diabetes: role of glycemic control. J Am SocNephrol 4(2): S86-9.
29. Bash LD, Selvin E, Steffes M, Coresh J, Astor BC (2008) Poor Glycemic Control in Diabetes and the Risk of Incident Chronic Kidney Disease Even in the Absence of Albuminuria and Retinopathy Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med 168(22): 2440-2447. doi:10.1001/archinte.168.22. 2440.
30. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS (2006) Body Mass Index and Risk for End-Stage Renal Disease. Ann Intern Med 144: 21-28. (Pubitemid 46780716)
31. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, et al. (2006) Obesity and Risk for Chronic Renal Failure J Am Soc Nephrol 17: 1695-1702.